Table 2. Data from the Psychometric Assessments and Side-Effect Rating Scale in Patients who Received Escitalopram, on Weeks 1, 4 and 8 of the Study.
| Scale | CC | CT | TT | p-value | ||||
| Week 1 | ||||||||
| HADS | 37.0 [36.0; 38.0] | 37.0 [36.0; 37.0] | 37.0 [36.0; 38.0] | 0.335 | ||||
| HAMD | 22.0 [21.0; 23.0] | 22.0 [21.0; 22.0] | 22.0 [21.0; 22.0] | 0.330 | ||||
| UKU | 1.0 [1.0; 1.0] | 1.0 [1.0; 1.0] | 1.0 [1.0; 1.0] | 0.359 | ||||
| Week 4 | ||||||||
| HADS | 27.0 [23.0; 30.0] | 26.0 [23.0; 29.0] | 20.0 [17.0; 22.0] | < 0.001 | ||||
| HAMD | 16.0 [14.0; 18.0] | 15.0 [14.0; 16.0] | 12.0 [10.0; 15.0] | < 0.001 | ||||
| UKU | 3.0 [2.0; 3.0] | 2.0 [2.0; 3.0] | 2.0 [1.0; 2.0] | < 0.001 | ||||
| Week 8 | ||||||||
| HADS | 16.0 [12.0; 19.0] | 5.0 [2.0; 9.0] | 3.0 [3.0; 5.0] | < 0.001 | ||||
| HAMD | 9.0 [7.0; 11.0] | 4.0 [2.0; 6.0] | 2.0 [1.0; 4.0] | < 0.001 | ||||
| UKU | 7.0 [7.0; 8.0] | 3.0 [3.0; 4.0] | 3.0 [2.0; 3.0] | < 0.001 | ||||
p – p-value obtained in Benjamini-Hochberg multiple testing correction (based on the results of Mann-Whitney U test), Data are presented as Me and IQR.